| Jennifer J Ebbott, LCSW | |
|
831 E Washington Ave, Madison, WI 53703-2935 | |
| (608) 255-7356 | |
| Not Available |
| Full Name | Jennifer J Ebbott |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 831 E Washington Ave, Madison, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013182419 | NPI | - | NPPES |
| 40962600 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 7109-123 (Wisconsin) | Primary |
| Entity Name | Open Door Center For Change, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215068069 PECOS PAC ID: 2860598711 Enrollment ID: O20070509000503 |
News Archive
Roche Molecular Systems, Inc. announced today a research collaboration with Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.) providing Merck access to Roche's developmental microarray-based AmpliChip p53 Test, which is designed to detect mutations in the tumor suppressor gene p53. By identifying cancers that harbor a dysfunctional p53 gene, the companies aim to achieve better treatment outcomes in cancer patients by determining which patients are most likely to respond to certain investigational therapeutic candidates.
Research teams led by Mayo Clinic have demonstrated for the first time that two types of colorectal pre-cancers can be detected through noninvasive stool DNA testing. The two studies being presented demonstrate that stool DNA testing may be useful for detection of premalignant dysplasia in patients with inflammatory bowel disease and of an important type of colorectal pre-cancer called serrated polyps.
Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company, announced today the publication of new research findings in the journal Nature describing the discovery and validation of the role of the gene Sort1 in the development of cardiovascular disease, including myocardial infarction (MI). This work was done with collaborators at University of Pennsylvania (UPenn) School of Medicine, Massachusetts General Hospital (MGH), and the Broad Institute. The collaborative effort combined genome-wide association studies (GWAS) and RNAi technology to identify and validate novel genes as targets for new therapies for heart disease.
Parkinson's Disease is the second most common neurodegenerative disorder. In Germany alone, almost half a million people are affected. The focus of the disease is the progressive degeneration of dopamine-producing nerve cells in a certain region of the midbrain, the substantia nigra. Misfolded proteins are the cause. Until recently, it was unclear why damage is confined to specific nerve cells.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer J Ebbott, LCSW 831 E Washington Ave, Madison, WI 53703-2935 Ph: () - | Jennifer J Ebbott, LCSW 831 E Washington Ave, Madison, WI 53703-2935 Ph: (608) 255-7356 |
News Archive
Roche Molecular Systems, Inc. announced today a research collaboration with Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.) providing Merck access to Roche's developmental microarray-based AmpliChip p53 Test, which is designed to detect mutations in the tumor suppressor gene p53. By identifying cancers that harbor a dysfunctional p53 gene, the companies aim to achieve better treatment outcomes in cancer patients by determining which patients are most likely to respond to certain investigational therapeutic candidates.
Research teams led by Mayo Clinic have demonstrated for the first time that two types of colorectal pre-cancers can be detected through noninvasive stool DNA testing. The two studies being presented demonstrate that stool DNA testing may be useful for detection of premalignant dysplasia in patients with inflammatory bowel disease and of an important type of colorectal pre-cancer called serrated polyps.
Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company, announced today the publication of new research findings in the journal Nature describing the discovery and validation of the role of the gene Sort1 in the development of cardiovascular disease, including myocardial infarction (MI). This work was done with collaborators at University of Pennsylvania (UPenn) School of Medicine, Massachusetts General Hospital (MGH), and the Broad Institute. The collaborative effort combined genome-wide association studies (GWAS) and RNAi technology to identify and validate novel genes as targets for new therapies for heart disease.
Parkinson's Disease is the second most common neurodegenerative disorder. In Germany alone, almost half a million people are affected. The focus of the disease is the progressive degeneration of dopamine-producing nerve cells in a certain region of the midbrain, the substantia nigra. Misfolded proteins are the cause. Until recently, it was unclear why damage is confined to specific nerve cells.
› Verified 9 days ago
Ms. Leah Allison Finch, CAPSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2500 Overlook Ter, Madison, WI 53705 Phone: 608-256-1901 | |
Mr. Thomas A Oconnor, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5534 Medical Circle, Madison, WI 53719 Phone: 608-274-0355 Fax: 608-274-5546 | |
Ms. Fran L Degraff, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2727 Marshall Ct, Madison, WI 53705 Phone: 608-238-9354 Fax: 608-238-7675 | |
Thorsten W. Horton, PHD Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 700 Ray O Vac Dr, Suite 220, Madison, WI 53711 Phone: 608-276-9191 Fax: 608-276-9144 | |
Erin Thomson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1500 Highland Ave, Room 102, Madison, WI 53705 Phone: 608-263-5815 | |
Julia Rhodes, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 700 Rayovac Dr, Ste 103, Madison, WI 53711 Phone: 608-238-5826 |